Huckabee ML, Butler SG, Barclay ML, Jit S. Submental surface electromyographic measurement and pharyngeal pressures during normal and effortful swallowing. Arch Phys Med Rehabil 2005; 86, 2144-9 [Abstract]
Begg EJ. Individualized drug and dose: the clinical pharmacologist's calling or curse? Clin Exp Pharmacol Physiol 2005; 32(11), 975-8 [Abstract]
Gardiner SJ, Begg EJ. Zhang M, Hughes RC. Transfer of rofecoxib into human milk. Eur J Clin Pharmacol 2005; 61(5-6), 405-8 [Abstract]
Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Intern Med J 2005; 35(10), 580-5 [Abstract]
Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005; 20(8), 1149-57 [Abstract]
Doogue MP, Begg EJ, Bridgman P. Clopidogrel Hypersensitivity Syndrome With Rash, Fever, and Neutropenia. Mayo Clin Proc 2005; 80(10), 1368-70 [Abstract]
Begg EJ. CD-ROM: Drug Identifier 2005 – The premier drug identification tool. NZ Med J 2005; 118(1208), 1283/1 [No abstract]
Moller PW, Begg EJ. Independent nurse prescribing in New Zealand. NZ Med J 2005; 118(1225), U1724/1-4 [Abstract]
Moller P, Begg E. Nurse practitioner (NP) prescribing in New Zealand: a NP's response to the editorial by Drs Moller and Begg (Reply). NZ Med J 2005; 118(1226), 1764/1-4 [No abstract]
Gearry R, Barclay M, Florkowski C, George P, Walmsley T. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation. NZ Med J 2005; 118(1214), 1444/1-7 [Abstract]
Sies C, Florkowski C, George P, Gearry R, Barclay M, Harraway J, Pike L. Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine. NZ Med J 2005; 118(1210), 1324/1-7 [Abstract]
Doogue M, Barclay M. Death due to butane abuse—the clinical pharmacology of inhalants. NZ Med J 2005: 118(1223), 1732/1-10 [Abstract]
Hanger C, Dalrymple J, Hepburn D. Systemic side effects from topical imiquimod. NZ Med J 2005; 1181223, 1682/1-4 [Abstract]
Gardiner SJ, Begg EJ. Pharmacogenetic testing for drug metabolizing enzymes - is it happening in practice? Pharmacogenet Genomics 2005; 15(5), 365-9 [Abstract]
Doogue M. Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance. NZ Med J 2005; 119(1246), 2334 [Abstract]
Leaper M, Johnston MJ, Barclay M, Dobbs BR, Frizelle FA. Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy 2004; 36(6), 499-503 [Abstract]